#USA #New York #Pomerantz Law Firm #Investor Alert #Sensus Healthcare

Pomerantz Law Firm Initiates Investigation into Sensus Healthcare, Inc.

Pomerantz LLP, a well-respected law firm known for its focus on corporate, securities, and antitrust class action litigation, has announced an investigation concerning Sensus Healthcare, Inc. This probe is meant to address concerns raised by investors regarding the company’s financial practices and potential securities fraud. Investors who are affected are encouraged to reach out to attorney Danielle Peyton for further information and support.

Understanding the Context

The focus of the investigation stems from Sensus Healthcare's disappointing financial performance reported for the second quarter of 2025. The company, listed on NASDAQ under the ticker symbol SRTS, reported a GAAP earnings-per-share figure of -$0.06, which was below the analysts' expectations by $0.09. Furthermore, the company’s revenue totaled $7.3 million, reflecting a significant year-over-year decline of 20.7% and falling $2 million short of estimates.

This downturn has been primarily attributed to a lower sales volume to a major client. Despite the struggles in unit sales, Sensus noted that it saw some growth in recurring revenue derived from Fair Deal Agreements, an aspect that offers some hope amidst the decline.

Market Reaction

The unfavorable earnings announcement caused Sensus’s shares to plummet dramatically. On August 8, 2025, the company's stock price dropped by $1.89, translating to a staggering 35.32% decrease, closing at $3.46. Such a drastic reduction in stock value raises serious questions about the management of the company and the information provided to investors.

The Role of Pomerantz LLP

With a rich history that dates back over 85 years, Pomerantz LLP has established itself as a leader in representing investors in class action lawsuits. Founded by Abraham L. Pomerantz, the firm has been instrumental in shaping the landscape of securities class actions and has a proven track record of achieving significant financial recoveries for shareholders.

The firm operates in multiple locations including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, reinforcing its substantial presence in the legal field. Their commitment is directed towards safeguarding the rights of those affected by corporate malpractices, fiduciary breaches, and securities fraud.

Taking Action

Investors who believe they have been adversely affected by Sensus Healthcare's recent financial disclosures are strongly recommended to engage with Pomerantz LLP. By joining the class action, disgruntled shareholders may hold the company accountable for its alleged shortcomings and receive potential restitution.

For more information, investors can contact attorney Danielle Peyton at Pomerantz LLP via her email [email protected] or by phone at 646-581-9980, extension 7980.

The unfolding situation at Sensus Healthcare serves as a reminder of the importance of transparency and integrity in corporate governance. As this investigation progresses, more details are sure to emerge, painting a clearer picture of the challenges and missteps faced by the company.

For continuous updates and insights related to this investigation and others like it, keep your eyes tuned to Pomerantz LLP and other reputable news sources.